Delivery Order SPE2DB22D2206-SPE2DB24FHX20

Award Date 6/25/24
Potential Completion Date 7/17/24
Potential Value $66K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $36,068.10, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The award is for the delivery of GAMUNEX-C 40 gram/400 ml vials, a pharmaceutical product, to support the DLA's medical supply requirements. The contract is a Firm Fixed Price Delivery Order awarded without a set-aside designation. It is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
This federal contract award, valued at $49,752.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GAMUNEX-C 40 gram/400 ml vial, a pharmaceutical product, with a performance period through December 6, 2024. The contract is a Delivery Order placed under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,963.20, is for the delivery of GAMUNEX-C 40 GRAM/400 ML VIAL 400ML, a medical product, with an ultimate completion date of April 24, 2025. This contract award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued...
This federal contract award, valued at $75,854.60, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The contract is for the delivery of GAMUNEX-C 40 GRAM/400 ML VIAL 400ML, a pharmaceutical product. The award is not designated under any set-aside program, indicating open competition. AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc., is the prime contractor. This contract is a delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,925.84 Firm Fixed Price Delivery Order covers the supply of GAMUNEX-C 40 GRAM/400 ML VIAL 400ML, a pharmaceutical product, with a period of performance through December 23, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical,...
This federal contract award, valued at $11,801.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GAMUNEX-C 20 GRAM/200 ML VIAL 200ML, a medical product, with a period of performance through March 17, 2025. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued...
This federal contract award, valued at $43,287.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of GAMUNEX-C 40 GRAM/400 ML VIAL 400ML, a medical product. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical to provide a comprehensive range of...
This federal contract award, valued at $3,606.60, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GAMUNEX-C 1 GRAM/10 ML VIAL 10ML, a pharmaceutical product, and has an ultimate completion date of November 21, 2024. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award, valued at $7,462.92, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of GAMUNEX-C 10 GRAM/100 ML VIAL 100ML, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $16,372.10 with a firm fixed price for the supply of GAMUNEX-C 20 GRAM/200 ML VIAL 200ML. The contract has an ultimate completion date of March 27, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FHX20
    Delivery Order

This federal contract award, valued at $66,014.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of GAMUNEX-C 40 GRAM/400 ML VIAL 400ML pharmaceutical products. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The current award does not have a set-aside designation and was issued on a full and open competition basis, highlighting Amerisourcebergen's competitive position in the federal pharmaceutical supply market.

Generated 9/24/24, 9:03 AM